Finished
Clinical Investigation of the Quality of Life Benefit of Using a Home Walking Exoskeleton for a Population of Multiple Sclerosis Patients.
NCT05835622 · Pôle Saint Hélier · Updated 25 Sept 2026
- What is being tested
- Keeogo; adviced home practice
- For
- Multiple Sclerosis
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 28 people. The full rules are on the registry page.
- Where
- France (6 sites)
- When
- Starts or started 1 Feb 2024, ends 18 Sept 2026. Registered 28 April 2023.
- Results
- None posted yet.
In the researchers' words
The goal of this clinical investigation is to evaluate the effectiveness of home use of a lightweight robotic lower limb exoskeleton as a walking aid device on quality of life in patients with multiple sclerosis with gait disorders. Participants will wear an exoskeleton (Keeogo) for 8 weeks at home during the experimental phase. This phase is compared to an 8-week control phase at home with advice on regular physical activity adapted to their abilities.
Sites
- Hospices Civils de Lyon - Hôpital Henry GabrielleSaint-Genis-Laval, Auvergne-Rhône-Alpes, France
- Pôle Saint HélierRennes, Brittany Region, France
- Hôpital Saint Philibert-Groupement des Hôpitaux de l'Institut Catholique de LilleLomme, Hauts-de-France, France
- Centre de rééducation Fonctionnelle Propara-MontpellierMontpellier, Occitanie, France
- CHU Angers- SSR Les CapucinsAngers, Pays de la Loire Region, France
- CHU Nantes site de Saint JacquesNantes, Pays de la Loire Region, France